Merkel Cell Carcinoma: Who is at risk?
Patient Power - Medical Information and Resources
Join Dr. Paul Nghiem, an expert on Merkel Cell Carcinoma (MCC), as we focus on the dangers of MCC, how the sun factors in and who is at risk.
Join Dr. Paul Nghiem, an expert on Merkel Cell Carcinoma (MCC), as we focus on the dangers of MCC, how the sun factors in and who is at risk.
read less
Download this podcast
Latest Episodes for this Channel
Wed December 24 2008
Join Dr. Paul Nghiem, an expert on Merkel Cell Carcinoma (MCC), as we focus on the dangers of MCC, how the sun factors in and who is at risk.
Join Dr. Paul Nghiem, an expert on Merkel Cell Carcinoma (MCC), as we focus on the dangers of MCC, how the sun factors in and who is at risk.
Join Dr. Paul Nghiem, an expert on Merkel Cell Carcinoma (MCC), as we focus on the dangers of MCC, how the sun factors in and who is at risk.
read less
Wed December 17 2008
A normal pregnancy term lasts about 40 weeks, but babies born prior to 37 weeks are considered pre-term or premature babies. In this special webcast, ...
read more
A normal pregnancy term lasts about 40 weeks, but babies born prior to 37 weeks are considered pre-term or premature babies. In this special webcast, Oregon Health and Science University
neonatologist Dr. Cynthia McEvoy will help listeners understand the various impacts of high-risk pregnancies. Hear more about warning signs of pre-term labor and health complications surrounding
pre-term births. W...
read more
A normal pregnancy term lasts about 40 weeks, but babies born prior to 37 weeks are considered pre-term or premature babies. In this special webcast, Oregon Health and Science University
neonatologist Dr. Cynthia McEvoy will help listeners understand the various impacts of high-risk pregnancies. Hear more about warning signs of pre-term labor and health complications surrounding
pre-term births. We will also hear from a patient who experienced a high-risk pregnancy.
read less
Tue December 16 2008
Lymphoma is a general term for cancers that develop in the lymphatic system and can be classified as either Hodgkin's disease or non-Hodgkin's lymphom...
read more
Lymphoma is a general term for cancers that develop in the lymphatic system and can be classified as either Hodgkin's disease or non-Hodgkin's lymphoma (NHL). Hear an update of the latest lymphoma
treatment research following the American Society of Hematology meeting.
Lymphoma is a general term for cancers that develop in the lymphatic system and can be classified as either Hodgkin's disease or non-Hodgkin's lymphoma (NHL). Hear an update of the latest lymphoma
treatment research following the American Society of Hematology meeting.
read less
Tue December 16 2008
The likelihood of an enlarged prostate increases as men age. Enlargement or benign prostatic hyperplasia (BPH) contributes to many problems, including...
read more
The likelihood of an enlarged prostate increases as men age. Enlargement or benign prostatic hyperplasia (BPH) contributes to many problems, including urinary complaints, changes in a man's quality
of life, interference with daily activities, alterations in sleep and changes in sexual function. In this ihealth program on Patient Power, Dr. Kevin McVary discusses the latest treatments options
for a...
read more
The likelihood of an enlarged prostate increases as men age. Enlargement or benign prostatic hyperplasia (BPH) contributes to many problems, including urinary complaints, changes in a man's quality
of life, interference with daily activities, alterations in sleep and changes in sexual function. In this ihealth program on Patient Power, Dr. Kevin McVary discusses the latest treatments options
for an enlarged prostate. Dr. McVary is a urologist on the medical staff of Northwestern Memorial Hospital and professor of Urology at Northwestern University's Feinberg School of Medicine. Dr.
McVary begins with an explanation of the prostate gland and what its function is. He goes on to discuss why men have BPH, and he contends that most men at some point in their life will have some
manifestation of these lower urinary tract symptoms (LUTS). Dr. McVary explains the various drug therapies available, detailing each treatment and talking about alternative approaches currently being
studied. When the condition is severe, surgical treatments become necessary. Dr. McVary helps us to understand the various approaches and the benefits of this option. He also addresses listener
questions concerning enlarged prostate at a young age and the relationship between prostate cancer and BPH. If you're looking for information or advice for an enlarged prostate and how best to
control your symptoms, this program will be a useful resource for you.
read less
Wed December 10 2008
With all the treatment options for prostate cancer out there, it can be difficult for men to make a decision. Joining host Andrew Schorr for a debate ...
read more
With all the treatment options for prostate cancer out there, it can be difficult for men to make a decision. Joining host Andrew Schorr for a debate on prostate cancer treatments is Dr. Bruce
Dalkin, a urologic oncologist at the Seattle Cancer Care Alliance. Two patients also join the program to share their stories. Ted Girgus suffers from stage IV prostate cancer, and Peter Frishauf
received a d...
read more
With all the treatment options for prostate cancer out there, it can be difficult for men to make a decision. Joining host Andrew Schorr for a debate on prostate cancer treatments is Dr. Bruce
Dalkin, a urologic oncologist at the Seattle Cancer Care Alliance. Two patients also join the program to share their stories. Ted Girgus suffers from stage IV prostate cancer, and Peter Frishauf
received a diagnosis of high PSA levels but had a negative biopsy. Peter is also the founder of Medscape, one of the leading websites to educate doctors. In addition to his work as an oncologist, Dr.
Dalkin studies how well different treatments work. He describes how this research is conducted, what he has learned and what it means for patients. Dr. Dalkin discusses what his research has shown
about the specific treatment options, including cryotherapy, brachytherapy, immunotherapy and finasteride. He also talks about when treatment is necessary and how it is possible to overtreat patients
in certain situations. Ted describes his journey with prostate cancer, from diagnosis to brachytherapy treatment 12 years ago. Peter discusses his experiences with various treatments and explains why
he decided to seek out better care than his first doctor could give. Dr. Dalkin's research sparks a debate about the effectiveness of treatments, and how to know whether a certain treatment is
effective. Listen to this webcast if you or someone you know is worried about prostate cancer. The guests talk about treatments for patients who have been diagnosed, as well as people like Peter, who
have been able to prevent onset. Listen now to learn more.
read less
Beauty Now: The Intersection of Cosmetic Surgery, Longevity & Bio-Medical Innovation
Free Relationship Advice During My Online Free Radio Show, "Life Support" From Marriage & Family Therapist, Lisa Dunning | BlogTalkRadio Feed
Hospice Radio with Zoë A. Lewis, M.D., FACP, DAAHPM. | BlogTalkRadio Feed
Intercoursing on ETIN